Potential of rosemary oil to be used in drug-resistant infections.
Suaib Luqman, Gaurav R Dwivedi, Mahendra P Darokar, Alok Kalra, Suman P S Khanuja
Index: Altern. Ther. Health Med. 13(5) , 54-9, (2007)
Full Text: HTML
Abstract
To evaluate the antimicrobial activity potential of the essential oil of rosemary specifically for its efficacy against the drug-resistant mutants of Mycobacterium smegmatis, Escherichia coli, and Candida albicans.Antibacterial, antifungal, and drug resistance-modifying activity was evaluated both qualitatively and quantitatively following disc diffusion and broth dilution assay procedures.The rosemary essential oil was found to be more active against the gram-positive pathogenic bacteria except E. faecalis and drug-resistant mutants of E. coli, compared to gram-negative bacteria. Similarly, it was found to be more active toward nonfilamentous, filamentous, dermatophytic pathogenic fungi and drug-resistant mutants of Candida albicans.Our findings suggest that characterization and isolation of the active compound(s) from the rosemary oil may be useful in counteracting gram-positive bacterial, fungal, and drug-resistant infections.
Related Compounds
Related Articles:
2010-10-01
[Food Microbiol. 27(7) , 889-96, (2010)]
2013-10-01
[Meat Science 95(2) , 235-41, (2013)]
Trial of a minimal-risk botanical compound to control the vector tick of Lyme disease.
2010-07-01
[J. Med. Entomol. 47(4) , 695-8, (2010)]
Prevention of retinal light damage by zinc oxide combined with rosemary extract.
2013-01-01
[Mol. Vis. 19 , 1433-45, (2013)]
Investigations into the specific effects of rosemary oil at the receptor level.
2010-07-01
[Phytomedicine 17(8-9) , 693-7, (2010)]